Hitachi Medical Systems America Announces New Scenaria SE 64/128-Slice CT Models

CLEVELAND--(BUSINESS WIRE)--Hitachi Medical Systems America, Inc., a leading provider of diagnostic imaging equipment announced FDA clearance to market two new models within its Scenaria Platform, the new Scenaria SE 64 and SE 128. The Scenaria SE models feature added work-flow-speed and ease of use capabilities to facilitate the higher daily scanning volumes of busy CT facilities. Scenaria SE models are Smart-Dose (XR-29) compliant, including lower dose* patient safety capabilities.

“Scenaria SE demonstrates Hitachi’s continuing commitment to provide compelling value-based CT solutions by enhancing the Scenaria Platform that is already recognized for premium 64/128-slice imaging technologies and exceptional patient accommodation features with added Speed and Ease of Use capabilities”

Scenaria SE adds significant platform enhancements that are highlighted by a 40% increases in both standard Recon Speed (to up to 50 images per second) and MPR Recon Speed with added automation of frequent use Operator functions, all combining to enhance workflow. Scenaria SE also includes an upgrade of the standard patient table weight capacity to 550lbs, for bariatric patient accommodation.

“Scenaria SE demonstrates Hitachi’s continuing commitment to provide compelling value-based CT solutions by enhancing the Scenaria Platform that is already recognized for premium 64/128-slice imaging technologies and exceptional patient accommodation features with added Speed and Ease of Use capabilities,” said Mark Silverman, Director of CT Marketing.

“With Scenaria SE, Hitachi is demonstrating again the unmatched value of our customer support by providing a no-charge upgrade to full Scenaria SE capabilities for our entire installed base of Scenaria 128 customers, covered by warranty or full service agreements. This upgrade is in addition to our exceptional commitments of unlimited no-charge Applications Training revisits and full replacement coverage of X-ray tubes without cost proration, under our warranty,” said Sheldon Schaffer, VP & General Manager MR/CT.

* In clinical use, dose saving features may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practices employed. Consultation with a radiologist and physicist are recommended to determine the appropriate dose needed to obtain diagnostic image quality for a particular clinical task.

About Hitachi Medical Systems America, Inc.

Hitachi Medical Systems America, Inc. (HMSA) located in Twinsburg, Ohio, a wholly owned subsidiary of Hitachi Medical Corporation offers a broad range of diagnostic imaging equipment including MRI, CT and Ultrasound. Our innovations in diagnostic imaging provide technology that drives clinical solutions to deliver diagnostic confidence, improve workflow efficiency and provide a better patient experience. In addition to exceptional equipment, HMSA is known for its comprehensive customer support programs to maximize the lifecycle value of equipment through responsive service maintenance, significant software upgrades and on-going applications support.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society’s challenges with our talented team and proven experience in global markets. The company’s consolidated revenues for fiscal 2013 (ended March 31, 2014) totaled 9,616 billion yen ($93.4 billion). Hitachi is focusing more than ever on the Social Innovation Business, which includes infrastructure systems, information & telecommunication systems, power systems, construction machinery, high functional material & components, automotive systems, health care and others. For more information on Hitachi, please visit the company’s website at http://www.hitachi.com.